Shire International

Takeda Pharmaceutical Company (TSE: 4502) is a global research and development-driven pharmaceutical company committed to bringing better health and a brighter future to patients by translating science into life-changing medicines. Takeda focuses its R&D efforts on oncology, gastroenterology and central nervous system therapeutic areas, plus vaccines. Around 30,000 Takeda employees are committed to improving quality of life for patients, working with partners in healthcare in more than 70 countries.